Physician profile
Kay E Elledge
NPI 1023055928
$1,171.34
in general payments reported to CMS, 2019-2025
10 companies · $189 in 2025
The $189 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $127 · 2020: $103 · 2021: $342 · 2022: $73.12 · 2023: $54.96 · 2024: $282 · 2025: $189.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $481 · Education: $45.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $481.01 |
| Education | $45.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exeltis, USA INC. | $335.22 | 2021-2025 | Slynd, Tyblume |
| Avion Pharmaceuticals | $262.93 | 2019-2023 | Balcoltra |
| Abbvie INC. | $238.30 | 2019-2021 | |
| Applied Medical Resources Corporation | $98.65 | 2024 | Gelpoint V-Path |
| Millicent US INC | $89.59 | 2025 | Femlyv, Intrarosa |
| Coloplast Corp | $51.18 | 2021 | |
| Hologic Sales and Service, LLC | $40.00 | 2022 | |
| Amag Pharmaceuticals, INC. | $23.91 | 2019 | |
| Mayne Pharma Commercial LLC | $16.17 | 2022 | |
| Ethicon US, LLC | $15.39 | 2024 | Ethicon |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kay Elledge listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.